Terveystalo (TTALO) Jefferies London Healthcare Conference 2025 presentation summary
Event summary combining transcript, slides, and related documents.
Jefferies London Healthcare Conference 2025 presentation summary
8 Sep, 2026Market trends and growth drivers
Aging population in Finland is increasing demand for healthcare, especially specialties related to aging, with the 65+ demographic expected to grow by 170,000 over the next decade.
Labor shortages in the public sector are acute, with a projected shortfall of 3,000 doctors and 14,000 nurses by 2025, creating opportunities for private providers.
Digitalization and remote care are accelerating, with public pay-private provision expected to rise and providers adapting their business models.
The addressable private healthcare market is projected to grow at a 5% CAGR.
Business performance and segment plans
Healthcare Services achieved LTM revenue of EUR 1,046 million and an adjusted EBIT margin of 14.4%, with a completed profitability improvement program and ongoing development agenda.
Portfolio Businesses reported LTM revenue of EUR 201 million and a 5% adjusted EBIT margin, with profitability improvements and growth via dental M&A and public partnerships.
Swedish operations had LTM revenue of EUR 77 million and a -3.2% adjusted EBIT margin, with profitability improvement and growth acceleration plans underway.
Digital platform and operational efficiency
Proprietary digital platform enhances efficiency and customer value, supporting B2B, B2C, and professional workflows, including appointment booking, triage, and remote services.
AI-enhanced platform (Ella) has significantly increased productivity, with professionals seeing more patients per day and reduced appointment times.
Self-service appointment booking rates rose to 83%, and remote appointments increased by 150%, outpacing the European average.
Latest events from Terveystalo
- Revenue and profit fell amid weak demand, but acquisitions and cost actions support future growth.TTALO
Q2 2026 - Acquisition forms a leading European outpatient care platform with strong synergies and EPS growth.TTALO
M&A announcement - €574 million deal forms Finland’s top eye health group, targeting €11–15M annual synergies.TTALO
M&A announcement - Revenue and profit dropped sharply, but digitalization and efficiency support gradual H2 recovery.TTALO
Q1 2026 - Profitability hit record highs despite lower revenue, with 2026 outlook cautious but optimistic.TTALO
Q4 2025 - Record profitability enables digital-driven growth and ambitious financial targets across business areas.TTALO
CMD 2024 - Record Q3 earnings and margin gains set the stage for a new growth-focused phase.TTALO
Q3 2024 - Record Q2 with 5.5% revenue growth, 49.1% EBITA increase, and raised 2024 margin guidance.TTALO
Q2 2024 - Strong growth and profitability in 2024, with improved margins and positive 2025 outlook.TTALO
Q4 2024